Christopher Johnson, OD
Optometrist · Dallas, OR
Christopher Johnson, OD is an optometrist with a practice address in Dallas, Oregon, and NPI 1740383116, issued on Sep 7, 2006. Check the license with the Oregon board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Christopher Johnson
- Credential
- OD
- Primary taxonomy
- Optometrist 152W00000X
- Practice location
- 986 SE Uglow Street, Dallas, OR 97338
- Phone
- (503) 623-3538
- Enumerated
- Sep 7, 2006
- Entity
- Type 1 · individual
Verify Christopher Johnson in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Oregon board licenses this professionCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
About as many Medicare Part D claims as the average optometrist in 2024
280 Medicare Part D claims for 82 beneficiaries, against an average of 279 among the 32,314 providers of this specialty who prescribed in Part D. Brand-name drugs were 21% of claims.
Most prescribed
- Latanoprost86 claims
- Timolol Maleate51 claims
- Brimonidine Tartrate31 claims
- Neomycin-Polymyxin-Dexameth27 claims
- Dorzolamide-Timolol13 claims
- Acyclovir12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $209.31
6 payments, mostly food and beverage; the largest payer was CooperVision Inc.. The 33,561 providers of this specialty with any payment received $749.79 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
5 optometrist records list a Dallas practice address
They are 5 of the 410 NPPES records with a Dallas practice address, and 916 optometrist records in Oregon.
All 5 in Dallas → All 916 in Oregon → Every provider in Dallas →
Other optometrist records in Oregon
- James Adamek, ODEagle Point, OR1568660199
- Brittany Adams, O.D.Albany, OR1265732978
- Makayla Adams, ODMyrtle Creek, OR1790461911
- Shelly Adams, O.D.White City, OR1396908075
- Samuel Adelman, O.D.Happy Valley, OR1043545122
- Brett Agost, O.D.Gresham, OR1326030883
- Dane AgostGresham, OR1376461657
- Andrew Aker, O.D.Portland, OR1154520906
- Joseph An, O.D.Gresham, OR1235271511
- Anna Anderson, O.D.Portland, OR1376707984
Common questions
What is Christopher Johnson, OD's NPI number?
Christopher Johnson, OD's National Provider Identifier (NPI) is 1740383116, issued on Sep 7, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Christopher Johnson, OD located?
The NPPES record lists a practice address at 986 SE Uglow Street, Dallas, OR, 97338. Phone: (503) 623-3538. Providers update this record themselves, so call before visiting.
How can I verify Christopher Johnson, OD's license?
Search the Oregon board that licenses this profession; the NPPES record confirms identity only.
How much does Christopher Johnson, OD prescribe under Medicare Part D?
In 2024, Christopher Johnson, OD had 280 Medicare Part D claims for 82 beneficiaries; the average among optometrist prescribers was 279. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.